Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Anna Barata, PhD
CONTACT
Daniella Landau
CONTACT
Lead
Massachusetts General Hospital
With
This study will examine the feasibility and acceptability of a digital symptom monitoring and management intervention (WAYPOINT) for improving symptom burden, quality of life and self-efficacy among patients treated with chimeric antigen receptor T-cell (CAR-T) therapy. The investigators will first refine WAYPOINT and then conduct a single-arm trial. During the refinement phase, 15 patients and 10 clinicians will provide feedback on WAYPOINT and inform further development of the intervention. Following refinement, a single arm trial involving 30 patients and 10 clinicians will evaluate the feasibility and acceptability of WAYPOINT for improving symptom burden, quality of life and self-efficacy after CAR-T therapy. Participation in this study is expected to last up to 90 days after enrollment. The National Institutes of Health is supporting this research by providing funding.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
